New Delhi: Drug firm Ipca Laboratories on Monday posted 44.18 per cent decline in net profit at Rs 23.18 crore for the third quarter ended December 31.
The company had posted a net profit of Rs 41.53 crore for the same period of previous fiscal.
Net sales of the company declined to Rs 674.27 crore for the third quarter as against Rs 734.15 crore in the same period of previous fiscal, Ipca Laboratories said in a regulatory filing.
Shares of the company were trading at Rs 628 on BSE, up 1.40 per cent from the previous close.
The company had posted a net profit of Rs 41.53 crore for the same period of previous fiscal.
Net sales of the company declined to Rs 674.27 crore for the third quarter as against Rs 734.15 crore in the same period of previous fiscal, Ipca Laboratories said in a regulatory filing.
Shares of the company were trading at Rs 628 on BSE, up 1.40 per cent from the previous close.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
